Search Results - "UKNIS, Marc E"

Refine Results
  1. 1
  2. 2

    Cytomegalovirus in transplantation - challenging the status quo by Fishman, Jay A, Emery, Vincent, Freeman, Richard, Pascual, Manuel, Rostaing, Lionel, Schlitt, Hans J, Sgarabotto, Dino, Torre-Cisneros, Julian, Uknis, Marc E

    Published in Clinical transplantation (01-03-2007)
    “…:  Background:  Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients causes both ‘‘direct’’ and ‘‘indirect’’ effects including allograft…”
    Get full text
    Journal Article
  3. 3

    Alpha‐1‐antitrypsin in cell and organ transplantation by Berger, Mel, Liu, Mingyao, Uknis, Marc E., Koulmanda, Maria

    Published in American journal of transplantation (01-07-2018)
    “…Limited availability of donor organs and risk of ischemia‐reperfusion injury (IRI) seriously restrict organ transplantation. Therapeutics that can prevent or…”
    Get full text
    Journal Article
  4. 4

    Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants by WENG, Francis L, PATEL, Anup M, WANCHOO, Rimda, BRAHMBHATT, Yasmin, RIBEIRO, Kezia, UKNIS, Marc E, MULGAONKAR, Shamkant, MATHIS, A. Scott

    Published in Transplantation (15-02-2007)
    “…The optimal regimen for prophylaxis of cytomegalovirus (CMV) disease after kidney and/or pancreas transplantation remains unclear. We compared the…”
    Get full text
    Journal Article
  5. 5

    Gene silencing in the endocrine pancreas mediated by short-interfering RNA by Bradley, Sean P, Rastellini, Cristiana, da Costa, Marco A, Kowalik, Timothy F, Bloomenthal, Aaron B, Brown, Melissa, Cicalese, Luca, Basadonna, Giacomo P, Uknis, Marc E

    Published in Pancreas (01-11-2005)
    “…RNA interference as mediated by short-interfering RNA (siRNA) offers a nonviral means to silence genes in tissue; however, few data exist about gene therapy…”
    Get full text
    Journal Article
  6. 6

    Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks by Grant, J Andrew, White, Martha V, Li, H Henry, Fitts, David, Kalfus, Ira N, Uknis, Marc E, Lumry, William R

    Published in Allergy and asthma proceedings (01-07-2012)
    “…Patients with hereditary angioedema (HAE) may have attacks triggered by dental, medical, or surgical procedures. This analysis evaluated the efficacy and…”
    Get more information
    Journal Article
  7. 7

    Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women by Baker, James W, Craig, Timothy J, Riedl, Marc A, Banerji, Aleena, Fitts, David, Kalfus, Ira N, Uknis, Marc E

    Published in Allergy and asthma proceedings (01-03-2013)
    “…Data are limited on hereditary angioedema (HAE) in pregnant women and the safety and efficacy of therapies for treatment and prevention of HAE attacks during…”
    Get more information
    Journal Article
  8. 8

    Renal Allograft Failure Predictors After PAK Transplantation: Results From the New England Collaborative Association of Pancreas Programs by PAVLAKIS, Martha, KHWAJA, Khalid, MANDELBROT, Didier, HONGYING TANG, WHITING, James W, LORBER, Marc I, GAUTAM, Amitabh, JOHNSON, Scott R, UKNIS, Marc E

    Published in Transplantation (15-06-2010)
    “…The reasons for kidney allograft failure subsequent to pancreas after kidney (PAK) are multifactorial; therefore, we examined these factors to identify a…”
    Get full text
    Journal Article
  9. 9

    Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema by Riedl, Marc A, Lumry, William R, Li, H Henry, Craig, Timothy J, Fitts, David, Kalfus, Ira, Uknis, Marc E

    Published in American journal of rhinology & allergy (01-11-2013)
    “…Laryngeal edema is a life-threatening manifestation of hereditary angioedema (HAE), an autosomal-dominant disorder caused by quantitative or functional C1…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Gene expression profiling of the donor kidney at the time of transplantation predicts clinical outcomes 2 years after transplantation by Bodonyi-Kovacs, Gabor, Putheti, Prabhakar, Marino, Miguel, Avihingsanon, Yingyos, Uknis, Marc E, Monaco, Anthony P, Strom, Terry B, Pavlakis, Martha

    Published in Human immunology (01-05-2010)
    “…Abstract We have previously demonstrated that biomarkers of inflammation and immune activity detected within intraoperative renal transplant allograft biopsies…”
    Get full text
    Journal Article
  12. 12

    Prophylaxis of cytomegalovirus disease in transplant patients by Uknis, Marc E

    Published in American journal of health-system pharmacy (15-04-2005)
    “…A historical perspective and the epidemiology, pathogenesis, and typical patient presentation of cytomegalovirus (CMV) disease in transplant patients; the…”
    Get full text
    Journal Article
  13. 13

    Enteric drainage of a pancreas allograft is safe for patients with celiac sprue by Akoad, Mohamed, Giraldo, Mauricio, Monaco, Anthony P, Hanto, Douglas W, Uknis, Marc E

    Published in Clinical transplantation (01-10-2002)
    “…Akoad M, Giraldo M, Monaco AP, Hanto DW, Uknis ME. Enteric drainage of a pancreas allograft is safe for patients with celiac sprue. Clin Transplant 2002: 16:…”
    Get full text
    Journal Article
  14. 14

    Design of a potent novel endotoxin antagonist by Uknis, Marc E, Wasiluk, Karen R, Acton, Robert D, Klaerner, Hans G, Dahlberg, Peter S, Ilyina, Elena E, Haseman, Judith R, Gray, Beulah H, Mayo, Kevin H, Dunn, David L

    Published in Surgery (01-08-1997)
    “…Background. Bactericidal permeability increasing protein (BPI) binds to and neutralizes lipopolysaccharide (LPS, endotoxin). Small synthetic peptides based on…”
    Get full text
    Journal Article
  15. 15

    Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors by Acton, R D, Dahlberg, P S, Uknis, M E, Klaerner, H G, Fink, G S, Norman, J G, Dunn, D L

    Published in Archives of surgery (Chicago. 1960) (01-11-1996)
    “…To determine the effect of targeted disruption of the cellular receptors of either tumor necrosis factor alpha (TNF-alpha) or interleukin-1 beta (IL-1 beta)…”
    Get more information
    Journal Article
  16. 16

    Macrophages expressing a fusion protein derived from bactericidal/permeability-increasing protein and IgG are resistant to endotoxin by Dahlberg, P S, Acton, R D, Uknis, M E, Klaerner, H G, Johnston, J W, Levelle, C D, Gray, B H, Dunn, D L

    Published in Archives of surgery (Chicago. 1960) (01-11-1996)
    “…To generate a recombinant fusion protein (FP) based on the endotoxin-binding domain of bactericidal/permeability-increasing protein (BPI) and the constant…”
    Get more information
    Journal Article
  17. 17

    Cytomegalovirus infection and disease after solid-organ transplantation: Epidemiology, prevention, and therapy by Uknis, Marc E., Dunn, David L.

    “…Disease caused by cytomegalovirus (CMV) infection remains one of the largest health concerns in clinical transplantation. CMV (transmitted to recipients before…”
    Get full text
    Journal Article
  18. 18

    Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis by KLAERNER, H. G, UKNIS, M. E, ACTON, R. D, DAHLBERG, P. S, CARLONE-JAMBOR, C, DUNN, D. L

    Published in The Journal of surgical research (01-07-1997)
    “…Candida albicans has been isolated with increasing frequency during intraabdominal infection; yet its role as a pathogen or copathogen remains controversial. A…”
    Get full text
    Conference Proceeding Journal Article
  19. 19

    Candida albicansandEscherichia coliAre Synergistic Pathogens during Experimental Microbial Peritonitis by Klaerner, Hans G., Uknis, Marc E., Acton, Robert D., Dahlberg, Peter S., Carlone-Jambor, Cassandra, Dunn, David L.

    Published in The Journal of surgical research (01-07-1997)
    “…Candida albicanshas been isolated with increasing frequency during intraabdominal infection; yet its role as a pathogen or copathogen remains controversial. A…”
    Get full text
    Journal Article
  20. 20

    Salvage therapy of open, infected surgical wounds: a retrospective review using Techni-Care by Grubbs, B C, Statz, C L, Johnson, E M, Uknis, M E, Lee, J T, Dunn, D L

    Published in Surgical infections (2000)
    “…To determine outcome of infected surgical wounds treated with 3% para-chloro-meta-xylenol + 3% phospholipid PTC [PCMX-PL] (Techni-Care). Retrospective review…”
    Get more information
    Journal Article